Sep 25 |
Medical Leader Lantheus Headed Toward Buy Point After Support At Key Level
|
Sep 25 |
Robust Quarterly Result Lifted Lantheus (LNTH) in Q2
|
Sep 22 |
Questor: A 300pc share price rise reflects the value of this cancer spotter
|
Sep 18 |
Lantheus Holdings (NASDAQ:LNTH) shareholder returns have been fantastic, earning 306% in 3 years
|
Sep 15 |
Lantheus Presents Results from the Primary Analysis of Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024
|
Sep 5 |
Lantheus Appoints Julie Eastland as New Board Member
|
Aug 28 |
We Ran A Stock Scan For Earnings Growth And Lantheus Holdings (NASDAQ:LNTH) Passed With Ease
|
Aug 28 |
Lantheus to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
|
Aug 20 |
Lantheus to Present Additional Clinical Data from Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024
|
Aug 14 |
Insider Sale: Director Gerard Ber Sells 15,500 Shares of Lantheus Holdings Inc (LNTH)
|